CycLex Met Kinase Assay/Inhibitor Screening Kit

1. Cooper, C.S., et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature. 311:29?33, 1984 2. Bottaro, D.P., et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:802?804, 1991 3. Schmidt, L., et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16:68?73, 1997 4. Schmidt, L., et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene. 18:2343?2350, 1999 5. Olivero, M., et al. Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. Int. J. Cancer.82:640?643, 1999 6. Park, W.S., et al. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res. 59:307?310, 1999 7. Lee, J.H., et al. A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene. 19:4947?4953, 2000 8. Di Renzo, M.F., et al. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene. 19:1547?1555, 2000 9. Comoglio, P.M., and Trusolino, L. Invasive growth: from development to metastasis. J. Clin. Invest. 109:857?862, 2002